COVID-19: Berlin scientists lay basis for a passive vaccination

(DZNE - German Center for Neurodegenerative Diseases) Researchers at the German Center for Neurodegenerative Diseases (DZNE) and Charité -- Universitätsmedizin Berlin have identified highly effective antibodies against the coronavirus SARS-CoV-2 and are now pursuing the development of a passive vaccination. In this process, they have also discovered that some SARS-CoV-2 antibodies bind to tissue samples from various organs, which could potentially trigger undesired side effects. They report th...